Montreal, QC -- February 07, 2019 -- InvestorsHub NewsWire --
Relevium Technologies Inc. (TSX.V:
“RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the
“Company” or “Relevium”), is
pleased to announce the new launch of the Push and Pull
System™, an
innovation in delivering a comprehensive solution for skin care,
designed specifically for today’s active women.
THE FIRST EVER The Push and Pull
System™
The Push & Pull System™ by Bioganix® is the first ever
comprehensive natural anti-aging system for complete skin care that
combines Collagen Protein supplements (PUSH) and naturally sourced
Aloe Vera skin anti-aging cream (PULL). This new launch is
targeting a brand-new revenue stream in the burgeoning
cosmeceutical market, which is the fastest growing segment of the
health and wellness Market.
OUR INITIAL TARGET AUDIENCE: HISPANIC WOMEN IN THE
USA
Relevium’s management has made the strategic decision to target
Hispanic women initially in the US for its revolutionary Push and
Pull System™. Hispanic women represent 17% of the
female population in the US or 28 million. According to Nielsen
Latina 2.0, Hispanic women are fiscally conscious, culturally
influential and are the gatekeeper of the Familia Health. The same
report explains that this segment of the US population is known to
spend almost 4X as much as Caucasian American women in the health
and beauty market.
Relevium is not the only company that believes this is an important
market. According to Adage Facts 2018, last year advertisers in the
US spent a staggering USD$9.2 billion marketing to 60 million
Hispanics or 18% of the total population of the country.
Furthermore, this is the fastest growing demographic segment in the
US, and it is estimated that Hispanics will represent 30% of the
population by 2050, almost doubling today’s numbers.
OUR MARKETING STRATEGY: DIRECT RESPONSE DIGITAL AND
TV
The Hispanic population in the US is a powerful consumer of
advertising lead primarily by television followed by digital media
and radio. As such, Relevium has decided to market Push and Pull
System™ primarily through direct response Television and digital
media, including social media.
The Company plans to launch its first direct response television
campaign, followed by digital and social media in the first quarter
of this year. As part of this campaign, the Company has retained
Daniela Kosan, a Venezuelan beauty queen, TV presenter, mother and
successful businesswoman to be the face of the unique Push and Pull
System™.
Aurelio Useche, CEO stated “The launch of Push and Pull System™
in the fasted growing segment of the health and wellness market
represents a major milestone for Relevium. The launch of the system
in the US Hispanic market provides a focused and disciplined new
approach to tailoring product offerings to customer needs of a
potentially highly responsive market” Aurelio further commented “We
believe with launching TV Commercials for this targeted market,
this will help drive a lot value to the Bioganix brand and further
increases our revenues”.
Abis Hussain CMO stated “The delivery of this new product
bundle is tailored to the fastest growing demographic segment in
the US, in which women are the major decision makers in terms of
health and wellness for their families. In addition to Direct
Response Television, our Company is building the supportive social
media infrastructure to ensure the brand quickly gains trusted
status in the target market”
To learn more about this new initiative, please
join Aurelio Useche CEO, Abis Hussain CMO and Faycal Salek CFO at
our upcoming shareholder web conference this Friday
February 8, 2019 at 16:30. To register for this
conference, please CLICK HERE.
About Relevium Technologies
Relevium is a publicly-traded company that operates in the health
and wellness industry, including legal cannabis, with a primary
focus on online distribution. The principal business of the Company
is the identification, evaluation, acquisition and operations of
brands and businesses in the Health and Wellness markets and
medical cannabis.
The Company pursues its business strategy through an acquisition
and partnership model in a holistic approach to encompass a wide
range of health and wellness consumer products. Relevium operates
through two wholly-owned subsidiaries:
BGX E-Health LLC (BGX): Based in Orlando, Florida, BGX markets
dietary supplements, nutraceuticals, sports nutrition and
cosmeceuticals primarily through its Bioganix® brand portfolio in
the US and Europe. Relevium’s brands such as Bioganix® are sold at
some of the world’s largest retailers including such as Walmart.com
and Amazon.com.
The Company’s strategy for growing its brands includes expanding
its product offering, adding new distribution channels and
developing partnerships that add value through exclusive
ingredients. BGX is currently testing a complete line of dietary
supplements derived from Cannabis with an initial focus on hemp
derived, whole plant organic extract rich in CBD (cannabidiol). The
product line will be marketed through its brand LeefyLyfe® and will
be sold first in Europe and then North America. The Company uses
cannabinoids and ingredients that have achieved GRAS status
(generally accepted as safe) to create brands that are sold via
wholesale channels, retail channels and online distribution.
Biocannabix Health Corporation (BCX): Based in Montreal, Quebec,
BCX is an entrepreneurial venture to establish a vertically
integrated research based medical cannabis company in the
Nutraceutical space.
Cautionary Note Regarding Forward-Looking
Statements
This release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws. All statements in this news
release, other than statements of historical facts, including
statements regarding future estimates, plans, objectives,
assumptions or expectations of future performance, including the
timing and completion of the proposed acquisitions, are
forward-looking statements and contain forward-looking information.
Generally, forward- looking statements and information can be
identified by the use of forward-looking terminology such as
“intends” or “anticipates”, or variations of such words and phrases
or statements that certain actions, events or results “may”,
“could”, “should”, “would” or “occur”. Forward-looking statements
are based on certain material assumptions and analysis made by the
Company and the opinions and estimates of management as of the date
of this press release. These forward-looking statements are subject
to known and unknown risks, uncertainties and other factors that
may cause the actual results, level of activity, performance or
achievements of the Company to be materially different from those
expressed or implied by such forward-looking statements or
forward-looking information. Important factors that may cause
actual results to vary, include, without limitation, the risk that
the proposed business developments may not occur as planned; the
timing and receipt of requisite approvals and failure to raise
sufficient funds.
Although management of the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in forward-looking statements or
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward- looking statements and
forward-looking information. Readers are cautioned that reliance on
such information may not be appropriate for other purposes. The
Company does not undertake to update any forward-looking statement,
forward-looking information or financial outlook that are
incorporated by reference herein, except in accordance with
applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
Chief Executive Officer
For more information about this press release:
RELEVIUM TECHNOLOGIES INC
Tel: +1.888.528.8687
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Relevium Technologies (CE) (USOTC:RLLVF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Relevium Technologies (CE) (USOTC:RLLVF)
Historical Stock Chart
From Dec 2023 to Dec 2024
